Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Clinical trial NCT07103746 · RECRUITING
Trial details
- NCT number
- NCT07103746
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2028-08-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.